Back to News
investment
Moderna’s stock rallies more than 10% as deal over a patent dispute clears vaccine pipeline
Claudia Assis
Loading...
1 min read
0 likes
Quantum News · Media Library
Understand this faster with AI
The deal would provide ‘certainty’ for Moderna’s vaccine portfolio.
Source Information
Source: MarketWatch
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.